eGene Inc. Announces Its HDA-GT12(TM) System That Shows Compatibility Of Detecting Influenza A Virus, Known As the Avian Flu Virus

IRVINE, Calif.--(BUSINESS WIRE)--May 4, 2006--eGene Inc. (OTCBB:EGEI - News), developers of rapid DNA analyzers, announced today that its HDA-GT12(TM) Genetic Analyzer shows compatibility of detecting the influenza A virus, commonly known as the avian flu virus. The automatic analysis process is less than six minutes. The company has demonstrated that its system platform can handle 12 RT-PCR amplified virus samples in six minutes, or at a sample analysis rate of two samples per minute.
MORE ON THIS TOPIC